Optogenetic strategies to investigate neural circuitry engaged by stress

Behavioural Brain Research

Volumn 255, Issue , 2013, Pages 19-25

  Sparta, Dennis R ^a   Jennings, Joshua H ^b   Ung, Randall L ^a   Stuber, Garret D ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

BNST; Circuit mapping; Optogenetics; Stress

Indexed keywords

ANIMAL BEHAVIOR; ANXIETY; BED NUCLEUS OF THE STRIA TERMINALIS; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN SLICE; CONNECTOME; FEAR; IN VIVO STUDY; NONHUMAN; OPTOGENETICS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; STRESS; STRIA TERMINALIS; SYNAPSE;

AAV; ADENO-ASSOCIATED VIRUS; AGOUTI-RELATED PEPTIDE; AGRP; ARC; ARCH; ARCHAERHODOPSIN; ARCUATE NUCLEUS OF THE HYPOTHALAMUS; AVIAN RETROVIRAL RECEPTOR; BASOLATERAL AMYGDALA; BED NUCLEUS OF THE STRIA TERMINALIS; BLA; BNST; CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASE IIΑ; CAMKIIΑ; CEA; CENTRAL NUCLEUS OF THE AMYGDALA; CHANNELRHODOPSIN-2; CHR2; CIRCUIT MAPPING; CORTICOTROPIN RELEASING FACTOR; CRF; DAT; DOPAMINE TRANSPORTER; GABA; HALORHODOPSIN; HERPES SIMPLEX VIRUS; HSV; LATERAL HABENULA; LATERAL HYPOTHALAMUS; LATERODORSAL TEGMENTUM; LDT; LED; LH; LHB; LIGHT EMITTING DIODE; MEA; MEDIAL NUCLEUS OF THE AMYGDALA; NAC; NEUROPEPTIDE Y; NPHR; NPY; NUCLEUS ACCUMBENS; OPTOGENETICS; PAG; PARABRACHIAL NUCLEUS; PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS; PBN; PERIAQUEDUCTAL GRAY; POMC; POST TRAUMATIC STRESS DISORDER; PRO-OPIOMELANOCORTIN; PRV; PSEUDORABIES VIRUS; PTSD; PVH; RABIES VIRUS ENVELOP GLYCOPROTEIN; RG; RMTG; ROSTROMEDIAL TEGMENTAL NUCLEUS; SNR; STRESS; SUBSTANTIA NIGRA RETICULATA; TETRODOTOXIN; TH; TTX; TVA; TYROSINE HYDROXYLASE; VESICULAR GABA TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTERS; VGAT; VGLUT; W; WATTS; Γ-AMINOBUTYRIC ACID;

ANIMALS; BRAIN MAPPING; NEURAL PATHWAYS; OPTOGENETICS; SEPTAL NUCLEI; STRESS, PSYCHOLOGICAL;

EID: 84884981910     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.05.007     Document Type: Review

References (80)

1. Selye H. A syndrome produced by diverse nocuous agents. 1936. Journal of Neuropsychiatry and Clinical Neurosciences 1998, 10:230-231.
2. Adamec R. Transmitter systems involved in neural plasticity underlying increased anxiety and defense--implications for understanding anxiety following traumatic stress. Neuroscience and Biobehavioral Reviews 1997, 21:755-765.
3. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129. 10.1016/S0893-133X(00)00195-0.
4. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109. 10.1038/sj.npp.1301574.
5. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Annals of the New York Academy of Sciences 2008, 1141:105-130. 10.1196/annals.1441.030.
6. Buchel C., Morris J., Dolan R.J., Friston K.J. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 1998, 20:947-957.
7. LaBar K.S., Gatenby J.C., Gore J.C., LeDoux J.E., Phelps E.A. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998, 20:937-945.
8. Phelps E.A., Delgado M.R., Nearing K.I., LeDoux J.E. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004, 43:897-905. 10.1016/j.neuron.2004.08.042.
9. Schulz D., Canbeyli R.S. Lesion of the bed nucleus of the stria terminalis enhances learned despair. Brain Research Bulletin 2000, 52:83-87.
10. Walker D.L., Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Structure & Function 2008, 213:29-42. 10.1007/s00429-008-0183-3.
11. Alheid G.F., et al. The neuronal organization of the supracapsular part of the stria terminalis in the rat: the dorsal component of the extended amygdala. Neuroscience 1998, 84:967-996.
12. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8:1263-1268. 10.1038/nn1525.
13. Chow B.Y., et al. High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 2010, 463:98-102. 10.1038/nature08652.
14. Yizhar O., Fenno L.E., Davidson T.J., Mogri M., Deisseroth K. Optogenetics in neural systems. Neuron 2011, 71:9-34. 10.1016/j.neuron.2011.06.004.
15. Zhang F., Wang L.P., Boyden E.S., Deisseroth K. Channelrhodopsin-2 and optical control of excitable cells. Nature Methods 2006, 3:785-792. 10.1038/nmeth936.
16. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702. 10.1038/nature07991.
17. Stuber G.D., et al. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 2011, 475:377-380. 10.1038/nature10194.
18. Tye K.M., et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362. 10.1038/nature09820.
19. Atasoy D., Betley J.N., Su H.H., Sternson S.M. Deconstruction of a neural circuit for hunger. Nature 2012, 488:172-177. 10.1038/nature11270.
20. Witten I.B., et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 2011, 72:721-733. 10.1016/j.neuron.2011.10.028.
21. van Zessen R., Phillips J.L., Budygin E.A., Stuber G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 2012, 73:1184-1194. 10.1016/j.neuron.2012.02.016.
22. Stuber G.D., Mason A.O. Integrating optogenetic and pharmacological approaches to study neural circuit function: current applications and future directions. Pharmacological Reviews 2013, 65:156-170. 10.1124/pr.111.005611.
23. Stamatakis A.M., Stuber G.D. Optogenetic Strategies to Dissect the Neural Circuits that Underlie Reward and Addiction 2012, vol. 2. Cold Spring Harbor Laboratory Press, New York, USA.
24. Tye K.M., Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nature Reviews Neuroscience 2012, 13:251-266. 10.1038/nrn3171.
25. Petreanu L., Huber D., Sobczyk A., Svoboda K. Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections. Nature Neuroscience 2007, 10:663-668. 10.1038/nn1891.
26. Wickersham I.R., et al. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 2007, 53:639-647. 10.1016/j.neuron.2007.01.033.
27. Watabe-Uchida M., Zhu L., Ogawa S.K., Vamanrao A., Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74:858-873. 10.1016/j.neuron.2012.03.017.
28. Chaudhury D., et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2012, 10.1038/nature11713.
29. Lammel S., et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217. 10.1038/nature11527.
30. Stamatakis A.M., Stuber G.D. Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance. Nature Neuroscience 2012, 15:1105-1107. 10.1038/nn.3145.
31. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424. 10.1038/nature06310.
32. Adamantidis A.R., et al. Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. Journal of Neuroscience 2011, 31:10829-10835. 10.1523/JNEUROSCI. 2246-11.2011.
33. Kravitz A.V., Tye L.D., Kreitzer A.C. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nature Neuroscience 2012, 15:816-818. 10.1038/nn.3100.
34. Lobo M.K., et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010, 330:385-390. 10.1126/science.1188472.
35. Tsai H.C., et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009, 324:1080-1084. 10.1126/science.1168878.
36. Tye K.M., et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2012, 10.1038/nature11740.
37. Cohen J.Y., Haesler S., Vong L., Lowell B.B., Uchida N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 2012, 482:85-88. 10.1038/nature10754.
38. Jennings J.H., et al. Distinct extended amygdala circuits for divergent motivational states. Nature 2013, 496:224-228. 10.1038/nature12041.
39. Sparta D.R., et al. Construction of implantable optical fibers for long-term optogenetic manipulation of neural circuits. Nature Protocols 2012, 7:12-23. 10.1038/nprot.2011.413.
40. Huber D., et al. Sparse optical microstimulation in barrel cortex drives learned behaviour in freely moving mice. Nature 2008, 451:61-64. 10.1038/nature06445.
41. Wentz C.T., et al. A wirelessly powered and controlled device for optical neural control of freely-behaving animals. Journal of neural engineering 2011, 8:046021. 10.1088/1741-2560/8/4/046021.
42. Kim T.I., et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 2013, 340:211-216. 10.1126/science.1232437.
43. Brog J.S., Salyapongse A., Deutch A.Y., Zahm D.S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. Journal of Comparative Neurology 1993, 338:255-278. 10.1002/cne.903380209.
44. Georges F., Aston-Jones G. Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. Journal of Neuroscience 2001, 21:RC160.
45. Georges F., Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. Journal of Neuroscience 2002, 22:5173-5187.
46. Jalabert M., Aston-Jones G., Herzog E., Manzoni O., Georges F. Role of the bed nucleus of the stria terminalis in the control of ventral tegmental area dopamine neurons. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:1336-1346. 10.1016/j.pnpbp.2009.07.010.
47. Ju G., Swanson L.W. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: I. Cytoarchitecture. Journal of Comparative Neurology 1989, 280:587-602. 10.1002/cne.902800409.
48. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. Journal of Comparative Neurology 1993, 332:1-20. 10.1002/cne.903320102.
49. Kudo T., Uchigashima M., Miyazaki T., Konno K., Yamasaki M., Yanagawa Y., et al. Three types of neurchemical projections from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. Journal of Neuroscience 2012, 32:18035-18046.
50. Poulin J.F., Arbour D., Laforest S., Drolet G. Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:1356-1365. 10.1016/j.pnpbp.2009.06.021.
51. Arluison M., et al. Demonstration of peptidergic afferents to the bed nucleus of the stria terminalis using local injections of colchicine. A combined immunohistochemical and retrograde tracing study. Brain Research Bulletin 1994, 34:319-337.
52. Gray T.S., Magnuson D.J. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. Journal of Comparative Neurology 1987, 262:365-374. 10.1002/cne.902620304.
53. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022. 10.1016/j.neuropharm.2006.06.011.
54. Li C., et al. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biological Psychiatry 2012, 71:725-732. 10.1016/j.biopsych.2011.11.015.
55. Merchenthaler I., Vigh S., Petrusz P., Schally A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. American Journal of Anatomy 1982, 165:385-396. 10.1002/aja.1001650404.
56. Phelix C.F., Paull W.K. Demonstration of distinct corticotropin releasing factor--containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat. Histochemistry 1990, 94:345-364.
57. Walter A., Mai J.K., Lanta L., Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. Journal of Chemical Neuroanatomy 1991, 4:281-298.
58. Christianson J.P., et al. Safety signals mitigate the consequences of uncontrollable stress via a circuit involving the sensory insular cortex and bed nucleus of the stria terminalis. Biological Psychiatry 2011, 70:458-464. 10.1016/j.biopsych.2011.04.004.
59. Hammack S.E., Richey K.J., Watkins L.R., Maier S.F. Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behavioral Neuroscience 2004, 118:443-448. 10.1037/0735-7044.118.2.443.
60. Lebow M., et al. Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis. Journal of Neuroscience 2012, 32:6906-6916. 10.1523/JNEUROSCI. 4012-11.2012.
61. McElligott Z.A., et al. Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:2271-2276. 10.1073/pnas.0905568107.
62. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34. 10.1016/j.neuron.2008.06.012.
63. Sullivan G.M., et al. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004, 128:7-14. 10.1016/j.neuroscience.2004.06.015.
64. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. Journal of Neuroscience 1997, 17:9375-9383.
65. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35:105-135. 10.1038/npp.2009.109.
66. Gewirtz J.C., McNish K.A., Davis M. Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1998, 22:625-648.
67. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 2003, 168:3-20. 10.1007/s00213-002-1224-x.
68. Buffalari D.M., See R.E. Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine. Psychopharmacology 2011, 213:19-27. 10.1007/s00213-010-2008-3.
69. Briand L.A., Vassoler F.M., Pierce R.C., Valentino R.J., Blendy J.A. Ventral tegmental afferents in stress-induced reinstatement: the role of cAMP response element-binding protein. Journal of Neuroscience 2010, 30:16149-16159. 10.1523/JNEUROSCI. 2827-10.2010.
70. Mahler S.V., Aston-Jones G.S. Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats. Journal of Neuroscience 2012, 32:13309-13326. 10.1523/JNEUROSCI. 2277-12.2012.
71. Choi D.C., et al. Chronic social stress in the visible burrow system modulates stress-related gene expression in the bed nucleus of the stria terminalis. Physiology and Behavior 2006, 89:301-310. 10.1016/j.physbeh.2006.05.046.
72. Funk D., Li Z., Le A.D. Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: Relationship to the reinstatement of alcohol seeking. Neuroscience 2006, 138:235-243. 10.1016/j.neuroscience.2005.10.062.
73. Kim S.J., et al. Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. Neuropharmacology 2006, 50:824-833. 10.1016/j.neuropharm.2005.12.003.
74. Shepard J.D., Schulkin J., Myers D.A. Chronically elevated corticosterone in the amygdala increases corticotropin releasing factor mRNA in the dorsolateral bed nucleus of stria terminalis following duress. Behavioural Brain Research 2006, 174:193-196. 10.1016/j.bbr.2006.07.019.
75. Sink K.S., et al. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Molecular Psychiatry 2012, 10.1038/mp.2011.188.
76. Erb S., Salmaso N., Rodaros D., Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 2001, 158:360-365. 10.1007/s002130000642.
77. Wang J., Fang Q., Liu Z., Lu L. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology 2006, 185:19-28. 10.1007/s00213-005-0262-6.
78. Lee Y.,F.S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
79. Gafford G.M., et al. Cell-type specific deletion of GABA(A)alpha1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:16330-16335. 10.1073/pnas.1119261109.
80. Kim S.Y., et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 2013, 496:219-223. 10.1038/nature12018.